Moreover, in bladder cancer, loss of E-cadherin expression is a marker of poor response to the monoclonal antibody cetuximab, which blocks EGFR binding and represses bladder cancer cell proliferation [55]. The gene discussed is CDH1; the disease is urinary bladder cancer.